SEC Form 4 · accession 0001209191-17-064705
SOPHIRIS BIO INC. · SPHS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter T Slover
Officer — Chief Financial Officer
Period of report
Dec 6, 2017
Accepted (ET)
Dec 8, 2017 · 4:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001563855
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock (Right to Buy)F1 | $1.91 | Dec 6, 2017 | A | 12,768 | A | Dec 6, 2018 | Dec 5, 2027 | Common Stock | 12,768 | 12,768 | D |
Explanation of responses
- F133% of the shares subject to the option shall vest one year after the date of grant. The remainder shall vest monthly thereafter over the next two years until fully vested on December 6, 2020.